BR112019017018A2 - formulações de canabinoides para o tratamento de dermatite e doenças de pele inflamatórias - Google Patents
formulações de canabinoides para o tratamento de dermatite e doenças de pele inflamatórias Download PDFInfo
- Publication number
- BR112019017018A2 BR112019017018A2 BR112019017018A BR112019017018A BR112019017018A2 BR 112019017018 A2 BR112019017018 A2 BR 112019017018A2 BR 112019017018 A BR112019017018 A BR 112019017018A BR 112019017018 A BR112019017018 A BR 112019017018A BR 112019017018 A2 BR112019017018 A2 BR 112019017018A2
- Authority
- BR
- Brazil
- Prior art keywords
- skin
- cbd
- pharmaceutical composition
- alcohol
- fact
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762459363P | 2017-02-15 | 2017-02-15 | |
| AU2017900495A AU2017900495A0 (en) | 2017-02-15 | Formulations of Cannabinoids for the Treatment of Dermatitis and Inflammatory Skin Diseases | |
| PCT/AU2018/050044 WO2018148785A1 (en) | 2017-02-15 | 2018-01-24 | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019017018A2 true BR112019017018A2 (pt) | 2020-04-14 |
Family
ID=67766794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019017018A BR112019017018A2 (pt) | 2017-02-15 | 2018-01-24 | formulações de canabinoides para o tratamento de dermatite e doenças de pele inflamatórias |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210401768A1 (enExample) |
| EP (1) | EP3582768A4 (enExample) |
| JP (2) | JP7012089B2 (enExample) |
| CN (1) | CN110545807B (enExample) |
| AU (1) | AU2018221880B2 (enExample) |
| BR (1) | BR112019017018A2 (enExample) |
| CA (1) | CA3053500A1 (enExample) |
| IL (1) | IL268720B2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020508992A (ja) * | 2017-02-15 | 2020-03-26 | ボタニクス ファーマシューティカルズ リミテッド | ざ瘡の処置のためのカンナビノイドの製剤 |
| BR112020014911A2 (pt) | 2018-01-24 | 2020-12-08 | Botanix Pharmaceuticals Ltd | Regime de dosagem de canabinoide para dermatite e condições de pele inflamatórias |
| CN111000740A (zh) * | 2020-01-07 | 2020-04-14 | 杭州百芮生物科技有限公司 | 一种添加大麻提取成分组合物、制备方法及其应用 |
| CN111671885A (zh) * | 2020-06-15 | 2020-09-18 | 中国人民解放军西部战区总医院 | 一种用于治疗放射性皮炎的药物 |
| CN111514280A (zh) * | 2020-06-15 | 2020-08-11 | 中国人民解放军西部战区总医院 | 一种预防放射性皮炎的药物 |
| CN113479456A (zh) * | 2021-04-06 | 2021-10-08 | 上海思乐得不锈钢制品有限公司 | 一种用于储运生物制品的真空容器 |
| US20230039887A1 (en) * | 2021-07-20 | 2023-02-09 | Enveric Biosciences, Inc. | Compositions for topical treatment of radiation dermatitis |
| US12059393B2 (en) | 2022-02-11 | 2024-08-13 | Akos Biosciences, Inc. | Compositions for topical treatment of radiation dermatitis |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0104268D0 (en) * | 2001-02-21 | 2001-04-11 | Unilever Plc | Antiperspirant or deodorant compositions |
| ES2312643T5 (es) * | 2001-07-18 | 2011-10-18 | Unilever N.V. | Composiciones para el tratamiento del cabello y/o del cuero cabelludo. |
| WO2008024408A2 (en) * | 2006-08-22 | 2008-02-28 | Theraquest Biosciences, Inc. | Pharmaceutical formulations of cannabinoids for application to the skin and method of use |
| US20080292560A1 (en) * | 2007-01-12 | 2008-11-27 | Dov Tamarkin | Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent |
| EP2444081B1 (en) * | 2010-10-19 | 2015-04-08 | Parenteral, A.S. | A composition for the treatment of inflammatory diseases comprising boswellic acids and cannabidiol |
| GB201019240D0 (en) * | 2010-11-15 | 2010-12-29 | Vib Vzw | Respiratory syncytical virus vaccine |
| US20130184354A1 (en) * | 2012-01-13 | 2013-07-18 | Donna K. Jackson | Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management |
| EP2664327A1 (en) * | 2012-05-14 | 2013-11-20 | Almirall S.A. | Topical pharmaceutical compositions comprising terbinafide and urea |
| NZ707855A (en) * | 2012-11-06 | 2018-11-30 | Rochal Ind Llc | Delivery of biologically-active agents using volatile, hydrophobic solvents |
| US20160022627A2 (en) * | 2014-04-18 | 2016-01-28 | Mary's Medicinals LLC | Transdermal cannabinoid patch |
| EP3265081A4 (en) * | 2015-03-02 | 2018-11-21 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with cannabinoids |
| HK1254812A1 (zh) * | 2015-06-23 | 2019-07-26 | APIRx Pharmaceuticals, LLC | 包含大麻素的抗微生物组合物 |
-
2018
- 2018-01-24 AU AU2018221880A patent/AU2018221880B2/en not_active Ceased
- 2018-01-24 EP EP18754514.0A patent/EP3582768A4/en active Pending
- 2018-01-24 CN CN201880023264.5A patent/CN110545807B/zh active Active
- 2018-01-24 CA CA3053500A patent/CA3053500A1/en active Pending
- 2018-01-24 BR BR112019017018A patent/BR112019017018A2/pt not_active IP Right Cessation
- 2018-01-24 IL IL268720A patent/IL268720B2/en unknown
- 2018-01-24 JP JP2019544865A patent/JP7012089B2/ja not_active Expired - Fee Related
- 2018-01-24 US US16/486,290 patent/US20210401768A1/en not_active Abandoned
-
2022
- 2022-01-17 JP JP2022005183A patent/JP2022050641A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018221880B2 (en) | 2023-08-17 |
| JP2020508994A (ja) | 2020-03-26 |
| IL268720A (en) | 2019-10-31 |
| CN110545807B (zh) | 2022-11-22 |
| EP3582768A4 (en) | 2020-11-18 |
| AU2018221880A1 (en) | 2019-09-05 |
| IL268720B2 (en) | 2024-09-01 |
| JP7012089B2 (ja) | 2022-01-27 |
| CN110545807A (zh) | 2019-12-06 |
| JP2022050641A (ja) | 2022-03-30 |
| US20210401768A1 (en) | 2021-12-30 |
| CA3053500A1 (en) | 2018-08-23 |
| IL268720B1 (en) | 2024-05-01 |
| EP3582768A1 (en) | 2019-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019017018A2 (pt) | formulações de canabinoides para o tratamento de dermatite e doenças de pele inflamatórias | |
| JP7559173B2 (ja) | 皮膚炎および炎症性皮膚状態のためのカンナビノイド投薬レジメン | |
| BR112019017049A2 (pt) | formulações de canabinoides para o tratamento de acne | |
| WO2018148785A1 (en) | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases | |
| WO2018148787A1 (en) | Formulations of cannabinoids for the treatment of psoriasis | |
| JP7561252B2 (ja) | ざ瘡のためのカンナビノイド投薬レジメン | |
| Salau et al. | Enhancement of transdermal permeation of cannabinoids and their pharmacodynamic evaluation in rats | |
| WO2018148786A1 (en) | Formulations of cannabinoids for the treatment of acne | |
| BR112019017011A2 (pt) | formulações de canabinoides para o tratamento de psoríase | |
| RU2440108C2 (ru) | Фармацевтическая композиция для лечения аллергических и воспалительных заболеваний кожи | |
| BR112019017045A2 (pt) | composições para tratar acne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021 |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2654 DE 16-11-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |